Huawei and WuXi AppTec Collaborate for the Creation of China Precision Medicine Cloud Platform

By CIOReview | Tuesday, March 22, 2016
751
1169
257

FREMONT, CA: It was publicized in an announcement made today, that Huawei and WuXi AppTec have signed a strategic framework agreement to support the China Precision Medicine Initiative (China PMI). The firms will create a state-of the-art precision medicine cloud platform to support the same.

Industry leading capabilities of the leading global information and communications technology provider, Huawei and the unrivalled genomics and precision medicine expertise WuXi NextCODE by WuXi AppTec has, are the features on which the agreement has been built. WuXi NextCODE is the global genomic information and precision medicine subsidiary of WuXi AppTec. "We are excited and honored to be working with Huawei as our key public cloud technology partner to support the China PMI. This partnership aims to deliver the benefits of genomic medicine to patients on an unprecedented scale, and together we have the world-leading technology to achieve that ambition," said Dr. Ge Li, Chairman and CEO, WuXi AppTec.

In order to deliver better healthcare and drive precision medicine innovation in a cost-efficient manner by using genomic big data, cloud computing technology can be leveraged and this is what the basis of this collaboration is.

China Food and Drug Administration’s guidance will be followed by the collaborated unit of WuXi AppTec and Huawei in working closely with third-party secure life-science cloud providers. This will enable the joint venture in data standards and exchange framework development that is required in delivering the China PMI. "This partnership is a win-win-win – for our companies and for the patients that will benefit from the vision of the China PMI. Our technology underpins genome-driven medicine at Genomics England, the Qatar Genome Project, Boston Children's Hospital and Harvard Medical School, and in China at Fudan University. We are thrilled to be deploying it with Huawei across China, a key part of our strategy to advance a global standard for turning the genome into better health," concluded Hannes Smarason, COO, WuXi NextCODE.